AdaptHealth Corp. AHCO
5.64
0.07
1.26%
as of 25 Sep
- Market cap
- $756.7M
- P/E
- 0.0×
Follow AHCO
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 15.98 |
+8 more quarters Free account |
P/S ratio |
0.42 | 0.49 | 0.41 | 0.39 | |
P/FCF ratio |
14.31 | 8.36 | 6.14 | 5.68 | |
P/Operating CF |
9.76 | 17.24 | 7.35 | 7.52 | |
P/B ratio |
1.02 | 1.07 | 0.88 | 0.75 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.98 | 1.04 | 0.93 | 0.94 | |
EV/EBITDA |
5.78 | 5.69 | 4.96 | 4.63 | |
EV/Operating CF |
5.64 | 5.70 | 5.00 | 5.12 | |
EV/FCF |
33.18 | 17.69 | 13.71 | 13.67 | |
Quick Ratio |
0.61 | 0.59 | 0.67 | 0.69 | |
Current Ratio |
1.12 | 0.92 | 1.02 | 1.08 | |
Net Debt/EBITDA |
14.62 | 15.96 | 9.95 | 10.59 | |
Debt/Assets |
44.08% | 41.89% | 40.98% | 40.67% | |
Debt/Equity |
1.38 | 1.22 | 1.16 | 1.10 | |
Asset Turnover |
0.78 | 0.74 | 0.74 | 0.70 | |
Operating CF/Net income |
(1.08) | (5.84) | (1.78) | 6.57 | |
Capex/Depreciation |
(0.63) | (1.11) | (0.46) | (0.95) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.98% | 11.70% | 11.12% | 10.98% | |
Intangible Assets out of Total Assets |
0.55 | 0.60 | 0.58 | 0.63 | |
Share Based Compensation of Revenue |
0.75% | 0.80% | 0.52% | 0.65% | |
Graham Net Nets |
(1.52) | (1.38) | (1.53) | (1.68) | |
Graham Number |
0.00 | 0.00 | 0.00 | 12.30 | |
Earnings Yield |
(16.31%) | (5.13%) | (5.42%) | 6.26% | |
Free Cash Flow Yield |
6.99% | 11.97% | 16.30% | 17.60% | |
Revenue per Share |
5.44 | 6.04 | 7.32 | 6.06 | |
Operating CF per Share |
1.07 | 0.69 | 1.36 | 1.19 | |
Capex per Share |
(1.22) | (0.88) | (0.77) | (0.70) | |
Free Cash Flow per Share |
(0.15) | (0.19) | 0.59 | 0.49 | |
Cash per Share |
0.32 | 0.35 | 0.79 | 0.59 | |
Shareholders Equity per Share |
10.18 | 11.15 | 11.29 | 12.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.18 | 11.15 | 11.29 | 12.01 | |
Free Cash Flow |
(20.94) | (26.05) | 79.29 | 66.82 | |
Working Capital |
88.26 | (55.81) | 16.51 | 54.13 | |
Capital Expenditures |
(166.24) | (119.77) | (103.90) | (94.24) | |
Net Current Asset Value |
(2,157.14) | (2,222.05) | (2,061.35) | (2,033.85) | |
EV/EBIT |
0.00 | 46.74 | 33.11 | 11.74 | |
Capex to Sales |
0.22 | 0.15 | 0.11 | 0.11 | |
Net Profit Margin |
(18.09%) | (1.96%) | (10.39%) | 2.99% | |
Price to Operating Income |
0.00 | 22.08 | 14.81 | 4.88 | |
| Other line items | |||||
Average Receivables |
391.99 | 405.21 | 389.46 | 390.77 | |
Average Payables |
526.75 | 511.29 | 495.84 | 476.04 | |
Average Inventory |
127.17 | 144.28 | 127.37 | 141.29 | |
Average Assets |
4,345.85 | 4,430.68 | 4,401.76 | 4,426.73 | |
Average Common Equity |
1,490.19 | 1,544.17 | 1,552.22 | 1,574.52 |
Columns are period end dates